UC-II (Undenatured Type II Collagen)

UC-II (Undenatured Type II Collagen) is a patented collagen supplement that preserves the natural triple-helix structure of type II collagen. It works through oral tolerance mechanisms to reduce joint inflammation and improve cartilage health.

Origin & History

UC-II is derived from chicken sternum cartilage and is processed using a patented method to preserve its undenatured form, which is essential for its joint health benefits.

Historical & Cultural Context

Collagen has been used in traditional medicine systems for joint health, with chicken cartilage being a common source in some cultures.

Health Benefits

- Supports joint comfort by modulating immune response, reducing joint pain by 33%. This is crucial for maintaining an active lifestyle. - Enhances cartilage health by preserving collagen structure, improving joint function. This aids in long-term joint mobility. - Reduces inflammation by modulating cytokine production, decreasing swelling. This is beneficial for individuals with arthritis. - Improves physical function by enhancing joint flexibility, increasing range of motion. This supports daily activities and exercise. - Supports immune health by reducing autoimmunity, protecting joint tissues. This is essential for overall joint health. - Aids in muscle recovery by reducing joint stiffness, enhancing post-exercise recovery. This benefits athletes and fitness enthusiasts. - Promotes long-term joint health by maintaining cartilage integrity, reducing degeneration. This is vital for aging individuals.

How It Works

UC-II works through oral tolerance by interacting with gut-associated lymphoid tissue (GALT) to modulate T-cell responses. The undenatured collagen structure allows immune recognition and subsequent downregulation of inflammatory cytokines like IL-1β and TNF-α. This process reduces autoimmune attacks on joint cartilage while preserving the extracellular matrix.

Scientific Research

Clinical trials have shown that UC-II can significantly improve joint comfort and mobility, with some studies indicating superior results compared to glucosamine and chondroitin.

Clinical Summary

A pivotal 90-day randomized controlled trial with 55 participants showed UC-II reduced joint pain by 33% and improved joint flexibility by 40% compared to placebo. Another study comparing 40mg UC-II to 1,500mg glucosamine plus 1,200mg chondroitin found UC-II was twice as effective for joint comfort. Multiple trials consistently demonstrate efficacy at low 40mg daily doses, though most studies have been relatively small with 50-100 participants.

Nutritional Profile

UC-II is a patented, standardized extract derived from chicken sternum cartilage, delivering undenatured (native) type II collagen as its primary bioactive compound. A typical serving dose is 40 mg per day, which is significantly lower than hydrolyzed collagen supplements (which are dosed at 5–10 g). At the 40 mg standardized dose: Undenatured Type II Collagen: 40 mg (standardized to contain approximately 25% type II collagen by weight, yielding ~10 mg active collagen per serving in some formulations; the key is the preservation of its native triple-helix 3D structure). Glycosaminoglycans (GAGs): Present as naturally occurring co-constituents within the cartilage matrix, including Chondroitin Sulfate (trace amounts, approximately 1–3 mg per 40 mg dose) and Hyaluronic Acid (trace amounts, <1 mg per 40 mg dose). These GAGs contribute to the mechanism of action. Protein content: Approximately 60–70% protein by dry weight of the extract, though the total protein per 40 mg dose is negligible from a macronutrient standpoint (~24–28 mg protein equivalent). Fat: Minimal, <1 mg per dose. Carbohydrates: Minimal, derived primarily from glycosaminoglycan sugar chains. Calories: Essentially negligible (<1 kcal per 40 mg dose). Bioavailability notes: The critical distinction of UC-II is that it is NOT hydrolyzed or denatured; it retains its native conformational epitopes, which are recognized by gut-associated lymphoid tissue (GALT), specifically Peyer's patches in the small intestine. This oral tolerance mechanism drives its immunomodulatory effects at very low doses. Bioavailability in the traditional absorption sense is not the primary mechanism — instead, immune modulation via GALT interaction is the key pathway, meaning efficacy is achieved at 40 mg rather than gram-level doses required for hydrolyzed collagen. Contains no significant vitamins or minerals. Allergen note: Derived from chicken; contraindicated for poultry allergies.

Preparation & Dosage

The recommended dosage of UC-II is 40 mg per day. Consult a healthcare provider before use.

Synergy & Pairings

Glucosamine, Chondroitin, MSM

Safety & Interactions

UC-II is generally well-tolerated with minimal reported side effects in clinical trials. As a protein derivative, individuals with severe egg or chicken allergies should exercise caution, though adverse reactions are rare. No significant drug interactions have been reported in clinical studies. Safety during pregnancy and breastfeeding has not been established, so use should be avoided during these periods.